易瑞生物：接受深圳前海恒江联合投资有限公司等机构调研

七印授权

47GSHPDVXD2FPCVIBF6WLNY5HZ113V321969HN7FDY51VPWH27

2025-03-07 11:28:59

article

848AC7756FAB91B1C8466856C537EA70C20A7A30BBD3B1290A921B334DFCFEA7

zh-CN

E60657A0DE3D77E94B4291B37BDEFA6186D29764

18034409

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

eaead7268aae3707766afb25547b229cb529ede544bb5161ba5b5d61e718e8a31c684866a29ff867ede35433297802b5222f947d6cc2969324523f07eb304db71b

{"parameters":{"adaptation":"n","authorized":"七印信息科技","price":"100000"},"type":"cm"}

yuanben_67cad87b769180.51836193

原本认证

15Q2DD8ZIFWWXO0UEPHVSJB6088PNECNA0Q5MNCHEJ0FUT1QIT

https://www.yuanben.io/article/c1626261-bece-41e9-88ef-c242d73bbc8a

{"author":"每日经济新闻","authorization_pub_key":"03040cbbeae1adf91c3efd7306d09c6005403a041f9b7405dac489d4f8126fef8c"}